Bilen, M. A., Brown, G. A., Singhal, M., Rossi, C., Kinkead, F., Wong, G., Palladino, A., Pilon, D., Morrow, C., Lowentritt, B. H. (2026). Real-world comparison of prostate-specific antigen (PSA) response in metastatic castration-sensitive prostate cancer (mCSPC) patients treated with apalutamide (APA) without docetaxel vs darolutamide (DARO) without docetaxel.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.106